EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Genotypes/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal

Hari Prasad Kattel, Sangita Sharma, Kristian Alfsnes iD, John H-O Pettersson iD, Rahul Pathak, Serina Beate Engebretsen, Komal Raj Rijal iD, Prakash Ghimire iD, Åshild K Andreassen iD, Megha Raj Banjara iD

Viruses · 06.03.2025 · 17 (3) · 377

DOI: 10.3390/v17030377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 06.03.2025. Verfasst von Hari Prasad Kattel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal. Hauptthemen laut MEDLINE: Hepacivirus, Antiviral Agents, Genotype, Drug Resistance, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian Agency for Development Co-operation (NORAD), Building Stronger Public Health Institutions and Systems (BIS) (2021-2025) project of the Norwegian Agency for Development Cooperation (NORAD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While direct-acting antivirals (DAAs) are available for the treatment of chronic Hepatitis C virus (HCV) patients in Nepal, knowledge of the circulating genotypes/subtypes and drug target gene mutations of HCV is currently unavailable. Here, we describe HCV genotypes/subtypes and identify antiviral target gene mutations in patients at a tertiary care hospital using genome data. A cross-sectional study was conducted from December 2019 to February 2024, where PCR followed by whole genome sequencing was performed to identify HCV genotypes/subtypes and drug target gene mutations. Among all the patients who tested positive for anti-HCV, 70.6% (149/211) were HCV RNA positive, while 68.2% (30/44) were genotype/subtype 3a, followed by 1a (18.2%, 8/44) and others (13.6%, 6/44), including new subtypes 3g and 3i from Nepal. Subtype 3a was also the dominant subtype (≥70%) among intravenous drug users and sexual routes of transmission. We found 70.5% of the samples with resistant mutations in the NS3/4A region, 22.7% in NS5A, and 45.5% in NS5B. Resistant mutations against sofosbuvir, pibrentasvir, velpatasvir, daclatasvir, and dasabuvir were found at 25%, 18%, 16%, 16%, and 2%, respectively, mostly on subtype 3a. The predominant HCV genotype/subtype in our patient group was 3a, and resistance mutations against direct-acting antivirals were found in most untreated patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusAntiviral AgentsGenotypeDrug Resistance, ViralHepatitis C, ChronicHepatitis CHumansNepalTertiary Care CentersCross-Sectional StudiesMaleFemaleMiddle AgedAdultMutationViral Nonstructural ProteinsPhylogenyAgedYoung Adult

Stichwörter der Autor:innen

Nepalantiviral drugshepatitis C virusresistant mutationssubtype

Substanzen

Antiviral AgentsViral Nonstructural Proteins

Autor:innen und Institutionen

  • Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
  • Tribhuvan University Teaching Hospital, Kathmandu 44601, Nepal.
  • Norwegian Institute of Public Health, P.O. Box 222, NO-0213 Oslo, Norway.
  • Zoonosis Science Center, Clinical Microbiology, Department of Medical Sciences, Uppsala University, SE-751 05 Uppsala, Sweden.
  • Department of Microbiology, Swedish Veterinary Agency, SE-751 05 Uppsala, Sweden.
  • Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3121, Australia.

ORCID-Profile: Kristian Alfsnes, John H-O Pettersson, Komal Raj Rijal, Prakash Ghimire, Åshild K Andreassen, Megha Raj Banjara

Förderung

  • Norwegian Agency for Development Co-operation (NORAD)
  • Building Stronger Public Health Institutions and Systems (BIS) (2021-2025) project of the Norwegian Agency for Development Cooperation (NORAD)

Zitieren

APA

Kattel, H. P., Sharma, S., Alfsnes, K., Pettersson, J. H., Pathak, R., Engebretsen, S. B., Rijal, K. R., Ghimire, P., Andreassen, Å. K., & Banjara, M. R. (2025). The Genotypes/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal. Viruses, 17(3), 377. https://doi.org/10.3390/v17030377

Vancouver

Kattel HP, Sharma S, Alfsnes K, Pettersson JH, Pathak R, Engebretsen SB, et al. The Genotypes/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal. Viruses. 2025;17(3):377. doi:10.3390/v17030377

BibTeX
@article{Kattel2025,
  author = {Kattel, Hari Prasad and Sharma, Sangita and Alfsnes, Kristian and Pettersson, John H-O and Pathak, Rahul and Engebretsen, Serina Beate and Rijal, Komal Raj and Ghimire, Prakash and Andreassen, Åshild K and Banjara, Megha Raj},
  title = {The Genotypes/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {377},
  doi = {10.3390/v17030377}
}
Kostenlos starten →